Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease

Effect of Comorbidity on Mortality in Patients With Peptic Ulcer Bleeding: Systematic Review and Meta-Analysis

(2013) Grigorios I Leontiadis et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease

(2013) M J Casanova et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study

(2013) Martin Bortlik et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure

(2012) Zuzana Zelinkova et al.   Clinical Gastroenterology and Hepatology

A suggestion and the larger perspective on the American College of Rheumatology/European League Against Rheumatism remission definitions: Comment on the article by Felson et al

(2011) Kent Johnson   ARTHRITIS AND RHEUMATISM

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

(2011) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Safety of infliximab use during pregnancy

(2011) Nada Djokanovic et al.   REPRODUCTIVE TOXICOLOGY

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics

(2010) Uma Mahadevan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Biologic therapy and pregnancy outcomes in women with rheumatic diseases

(2009) Evelyne Vinet et al.   ARTHRITIS AND RHEUMATISM

Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding

(2009) Javier P. Gisbert   INFLAMMATORY BOWEL DISEASES

ORIGINAL ARTICLE: Treatment with Adalimumab (Humira®) and Intravenous Immunoglobulin Improves Pregnancy Rates in Women Undergoing IVF*

(2008) Edward E. Winger et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

ORIGINAL ARTICLE: Treatment with Tumor Necrosis Factor Inhibitors and Intravenous Immunoglobulin Improves Live Birth Rates in Women with Recurrent Spontaneous Abortion

(2008) Edward E. Winger et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Outcomes of Obstetric Hospitalizations Among Women With Inflammatory Bowel Disease in the United States

(2008) Geoffrey C. Nguyen et al.   Clinical Gastroenterology and Hepatology